Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology group

被引：0
|
作者：
Zagouri, F. [1 ]
Bamias, A. [5 ]
Papakostas, P. [2 ]
Karadimou, A. [1 ]
Bournakis, E. [1 ]
Dimopoulos, M. [1 ]
Fountzilas, G. [3 ]
Papadimitriou, C. A. [4 ]
机构：
[1] Univ Athens, Sch Med, Dept Clin Therapeut, GR-11527 Athens, Greece
[2] Hippocrateio Hosp, Dept Med Oncol, Athens, Greece
[3] Aristotle Univ Thessaloniki, Sch Med, Dept Med Oncol, Thessaloniki, Greece
[4] Univ Athens, Sch Med, Alexandra Hosp, Dept Clin Therapeut, GR-11527 Athens, Greece
[5] Univ Athens, Sch Med, Dept Clin Therapeut 1, GR-11527 Athens, Greece
来源：
BREAST | 2009年 / 18卷
关键词：
D O I：
10.1016/S0960-9776(09)70210-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [21] Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study
    Fountzilas, G
    Nicolaides, C
    Bafaloukos, D
    Kalogera-Fountzila, A
    Kalofonos, H
    Samelis, G
    Aravantinos, G
    Pavlidis, N
    CANCER INVESTIGATION, 2000, 18 (06) : 503 - 509
  • [22] A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma
    Kim, Young Saing
    Lee, Soon Il
    Park, Se Hoon
    Park, Silvia
    Hwang, In Gyu
    Lee, Sang-Cheol
    Sun, Jong-Mu
    Lee, Jeeyun
    Lim, Ho Yeong
    CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : 76 - 81
  • [23] Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG)
    Zimpfer-Rechner, C
    Hofmann, U
    Figl, R
    Becker, JC
    Trefzer, U
    Keller, I
    Hauschild, A
    Schadendorf, D
    MELANOMA RESEARCH, 2003, 13 (05) : 531 - 536
  • [24] A multicentre, randomised phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer
    Tabernero, J
    Climent, MA
    Lluch, A
    Albanell, J
    Vermorken, JB
    Barnadas, A
    Antón, A
    Laurent, C
    Mayordomo, JI
    Estaun, N
    Losa, I
    Guillem, V
    Garcia-Conde, J
    Tisaire, JL
    Baselga, J
    ANNALS OF ONCOLOGY, 2004, 15 (09) : 1358 - 1365
  • [25] An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic Co-Operative Oncology Group
    Pectasides, D
    Kalofonos, HP
    Samantas, E
    Nicolaides, C
    Papacostas, P
    Onyenadum, A
    Visvikis, A
    Skarlos, D
    Fountzilas, G
    ANTICANCER RESEARCH, 2001, 21 (4B) : 3005 - 3010
  • [26] Phase II study of weekly docetaxel in patients with metastatic breast cancer
    Aihara, T
    Kim, Y
    Takatsuka, Y
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 286 - 292
  • [27] Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group
    Fountzilas, G
    Stathopoulos, G
    Nicolaides, C
    Kalogera-Fountzila, A
    Kalofonos, H
    Nikolaou, A
    Bacoyiannis, C
    Samantas, E
    Papadimitriou, C
    Kosmidis, P
    Daniilidis, J
    Pavlidis, N
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 475 - 478
  • [28] Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: A multicenter phase II trial
    Mavroudis, D
    Malamos, N
    Alexopoulos, A
    Kourousis, C
    Agelaki, S
    Sarra, E
    Potamianou, A
    Kosmas, C
    Rigatos, G
    Giannakakis, T
    Kalbakis, K
    Apostolaki, F
    Vlachonicolis, J
    Kakolyris, S
    Samonis, G
    Georgoulias, V
    ANNALS OF ONCOLOGY, 1999, 10 (02) : 211 - 215
  • [29] Weekly paclitaxel in metastatic breast cancer patients: A phase II study
    Gori, S
    Mosconi, AM
    Basurto, C
    Cherubini, R
    De Angelis, V
    Tonato, M
    Colozza, M
    TUMORI, 2002, 88 (06) : 470 - 473
  • [30] Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group
    Pectasides, D.
    Samantas, E.
    Fountzilas, G.
    Briasoulis, E.
    Kosmidis, P.
    Skarlos, D.
    Dimopoulos, M. A.
    Kalofonos, H. P.
    Economopoulos, T.
    Syrigos, K.
    LUNG CANCER, 2007, 58 (03) : 355 - 361
12345